RETINOIDS AND SMALL MOLECULES AS NRF2 ANTAGONISTS FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL CELL PROLIFERATION

摘要

The present invention relates to an improved assay for identifying compounds that may be of use in conjunction with cancer chemotherapeutic agents and anti-proliferative agents, to improve efficacy of such agents and/or render effective compounds with relatively little therapeutic activity. There is also provided a class of compounds of formula (I) and retinoids identified by said assay which may be used in a combination therapy, with current and novel agents, to treat cancers and other diseases associated with abnormal host cell proliferation, such as psoriasis.